News

AddToAny

Google+ Facebook Twitter Twitter

Pioneering studies in paleogenomics

The 18th annual Wiley Prize in Biomedical Sciences will be awarded to Svante Pääbo and David Reich for sequencing the genomes of ancient humans and extinct relatives.

Their work reveals the origin and ancestry of contemporary humans and our diverse populations. Svante Pääbo Director at the Max-Planck Institute for Evolutionary Anthropology in Leipzig, Germany. David Reich, is a Professor in the Department of Genetics at Harvard Medical School.

Titia de Lange, Chairperson of the Awards Jury for the Wiley Prize at The Rockefeller University in New York City, praised their work.

“The 2019 Wiley Prize recognises Svante Pääbo and David Reich for their pioneering studies of ancient human DNA that revealed the origin and migration of contemporary humans and our relationship to extinct relatives,” she said. “The Wiley Foundation honours research that champions novel approaches and challenges accepted thinking in the biomedical sciences.”

Related Articles

neutrophil cell trapping bacteria Image Credit | Science Photo Library-p2760184

Cancer and stress breakthrough

Stress hormones can trigger the formation of structures that make body tissues more susceptible to metastasis, research has found.

Tuberculosis vaccine bacteria-Image Credit | Science Photo Library - b2201433

“TB vaccine shrinks mice cancer tumours”

A new study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumour burden and extended the survival of mice with liver cancer.

genetics mutations cancer - CREDIT - alamy-2jkftm9

The evolution of cancer

Charlie Swanton outlines the work in cancer research that led to him being awarded a 2024 Louis-Jeantet Prize for translational medicine.

A nurse takes the blood pressures of a woman as she waits with an infant at Ndirande Health Centre in Blantyre on February 21, 2018 - Image credit - Getty-922184246

Vaccine effective in preventing typhoid fever

A single dose of the typhoid conjugate vaccine Typbar TCV provides lasting efficacy in preventing typhoid fever in children aged nine months to 12 years old, according to a new study.

Top